Roshawn Blunt is the Managing Director of 1798 Consultants, a consultancy that focuses on market access planning which she founded. She has more than 20 years of experience in the biopharmaceutical and medical device industries beginning with her position at The Boston Consulting Group, where she worked primarily on healthcare cases. She transitioned into positions directly with manufacturers in various roles in reimbursement, market access, health policy, and global health economics at Amgen and Johnson and Johnson. Ms. Blunt worked also on the provider side as the vice president of strategy at a hospital system. She received an A.B. degree in international and public affairs from Princeton University and an M.B.A. from The Kellogg Graduate School of Management at Northwestern University.